Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Conformis, Inc.    CFMS

CONFORMIS, INC.

(CFMS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
1.32(c) 1.23(c) 1.39(c) 1.4(c) 1.32(c) Last
5 065 100 2 678 454 4 999 404 4 122 342 3 089 314 Volume
+8.20% -6.82% +13.01% +0.72% -5.71% Change
More quotes
Financials (USD)
Sales 2020 67,9 M - -
Net income 2020 -28,4 M - -
Net cash position 2020 28,0 M - -
P/E ratio 2020 -3,33x
Yield 2020 -
Sales 2021 79,6 M - -
Net income 2021 -24,5 M - -
Net cash position 2021 27,0 M - -
P/E ratio 2021 -3,88x
Yield 2021 -
Capitalization 113 M 113 M -
EV / Sales 2020 1,26x
EV / Sales 2021 1,09x
Nbr of Employees 267
Free-Float 93,0%
More Financials
Company
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. 
More about the company
Notations Surperformance© of Conformis, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CONFORMIS, INC.
01/22CONFORMIS : SITES Medical to Collaborate on Knee Replacement Technology
MT
01/21Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
GL
01/07CONFORMIS : to Release Fourth Quarter and Fiscal Year 2020 Financial Results on ..
AQ
2020Conformis, Inc. to Participate in Upcoming Investor Conferences
GL
2020CONFORMIS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Ru..
AQ
2020Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
GL
2020CONFORMIS : to Participate in the 32nd Annual Piper Sandler Healthcare Conferenc..
AQ
2020Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Co..
GL
2020CONFORMIS : Announces Bart Lagae as VP, International Sales & Marketing; Inducem..
AQ
2020Conformis Announces Bart Lagae as VP, International Sales & Marketing; Induce..
GL
2020CONFORMIS : 3Q Earnings Snapshot
AQ
2020CONFORMIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020Earnings Flash (CFMS) CONFORMIS Reports Q3 Revenue $16.1M, vs. Street Est of ..
MT
2020CONFORMIS INC : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020CONFORMIS : Reports Third Quarter 2020 Financial Results
AQ
More news
News in other languages on CONFORMIS, INC.
2020CONFORMIS, INC. : Veröffentlichung des Jahresergebnisses
2020CONFORMIS, INC. : publication des résultats annuels
2018CONFORMIS INC : publication des résultats annuels
2018CONFORMIS INC : Veröffentlichung des Jahresergebnisses
2016GNW-NEWS : Studie ermittelt hohe Zufriedenheit von Patienten mit individuell ang..
More news
Chart CONFORMIS, INC.
Duration : Period :
Conformis, Inc. Technical Analysis Chart | CFMS | US20717E1010 | MarketScreener
Technical analysis trends CONFORMIS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 2,33 $
Last Close Price 1,32 $
Spread / Highest target 127%
Spread / Average Target 76,8%
Spread / Lowest Target 51,5%
EPS Revisions
Managers and Directors
NameTitle
Mark A. Augusti President, Chief Executive Officer & Director
Kenneth P. Fallon Chairman
Gary Maingot Senior Vice President-Operations
Robert Howe CFO, Treasurer & Principal Accounting Officer
Marc Quartulli Vice President-Clinical Affairs & Market Access
Sector and Competitors
1st jan.Capitalization (M$)
CONFORMIS, INC.100.00%113
STRYKER CORPORATION-2.09%90 163
SMITH & NEPHEW PLC6.69%19 774
INSPIRE MEDICAL SYSTEMS, INC.17.40%5 948
VENUS MEDTECH (HANGZHOU) INC.20.24%4 946
GLAUKOS CORPORATION15.83%3 917